InvestorsObserver
×
News Home

Should Biotechnology Stock Mediwound Ltd (MDWD) Be in Your Portfolio Thursday?

Thursday, September 28, 2023 02:32 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Mediwound Ltd (MDWD) Be in Your Portfolio Thursday?

A rating of 62 puts Mediwound Ltd (MDWD) near the middle of the Biotechnology industry according to InvestorsObserver. Mediwound Ltd's score of 62 means it scores higher than 62% of stocks in the industry. Mediwound Ltd also received an overall rating of 48, putting it above 48% of all stocks. Biotechnology is ranked 76 out of the 148 industries.

Overall Score - 48
MDWD has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on MDWD!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Mediwound Ltd Stock Today?

Mediwound Ltd (MDWD) stock is trading at $10.60 as of 2:31 PM on Thursday, Sep 28, a gain of $1.40, or 15.2% from the previous closing price of $9.20. The stock has traded between $8.82 and $10.60 so far today. Volume today is high. So far 55,530 shares have traded compared to average volume of 27,832 shares. Click Here to get the full Stock Report for Mediwound Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App